CYP2D6 and systemic lupus erythematosus: Therefore, we hypothesised that patients with SLE with the CYP2D6*10 (rs1065852) GG genotype might have good treatment responses when taking HCQ 400 mg/day, although the CIs were wide which implied a high degree of variability and uncertainty in the data.